The FOCUS Self-Assessment Examination program is intended to assist psychiatrists in keeping abreast of new knowledge and scientific developments in the field of psychiatry and in maintaining a lifelong learning program that will fulfill the needs of self-assessment and ongoing Maintenance of Certification. The topics for the 2017 Focus program are:
- Anxiety Disorders
- Collaborative Care
- Neurocognitive Disorders
- Posttraumatic Stress Disorder
The FOCUS examination may also be useful in studying for other examinations, such as the Psychiatry Recertification Examination of the American Board of Psychiatry and Neurology. Note: Although it is anticipated that participation in the FOCUS study and self-assessment examination will be helpful for psychiatrists taking other examinations, no guarantee concerning actual performance on other examinations is intended or implied. The American Board of Psychiatry and Neurology has developed a 10-year MOC program that includes self-assessment. The FOCUS Self-Assessment Examination is a broad-based self-assessment activity approved by the ABPN for this purpose.
This activity is only available to 2017 Focus subscribers.
Don't have a subscription to 2017 Focus? Subscribe by phone at 1-800-368-5777.
If you have questions about Focus subscriptions, please contact email@example.com.
At the completion of the activity, participants will:
- Have an increased understanding of current knowledge and new developments in psychiatric diagnosis and treatment and be able to apply this information to improve patient care;
- Recognize areas where more study is needed; and
- Validate current practice or make improvements in professional practice.
This program is one element of a lifelong learning program for physicians and as an aid for psychiatrists studying for recertification.
Estimated Time to Complete
Estimated Duration: 24 hours
Program Release Date: October 1, 2017
Program End Date: October 31, 2020 (11:59pm ET)
How to Earn Credit
To earn credit for the FOCUS Self-Assessment, participants complete all questions and the evaluation and review their score. The minimum performance level requirement is fulfilled by answering all questions and by receipt of a score and peer comparison. This activity is designed to identify areas for improvement and further study; credit will be awarded for completion of the self-assessment.
The answers, rationales, and references for further study are provided. We urge that as a minimum, the rationale for each question answered incorrectly be reviewed. Many participants may wish to review the rationales for all of the multiple choice questions. Participants will receive a detailed score report and peer comparison online. The peer comparison is a dynamic report and will change as participation increases. After completing the course, you can then claim and print your CME certificate.
The American Psychiatric Association (APA) is accredited by ACCME to provide continuing medical education for physicians. APA designates this enduring material CME activity for a maximum of 24 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABPN Approval for MOC Part 2 (Self-Assessment)
The American Board of Psychiatry and Neurology strongly supports an organized plan of lifelong learning for its psychiatric diplomates and reviews specific APA Category 1 CME activities for this purpose. The American Board of Psychiatry and Neurology has reviewed FOCUS: The Journal of Lifelong Learning in Psychiatry and the FOCUS Self-Assessment Examination and has approved this program as part of a comprehensive lifelong learning and self-assessment program, which is mandated by the ABMS as a necessary component of Maintenance of Certification, Part 2.
APA reports MOC completion data on behalf of our members directly to ABPN, however, diplomates are still required to log on to their ABPN Physician Folios at least once per calendar year to attest to completion of their MOC activities.
Royal College of Physicians and Surgeons of Canada
This activity is an Accredited Self-Assessment Program (Section 3) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, and approved by the Canadian Psychiatric Association. You may claim a maximum of 24 hours (credits are automatically calculated).
Faculty and Planner Disclosures
No financial affiliations with commercial organizations
- Mark Hyman Rapaport, M.D., Chairman, Department of Psychiatry, Emory University School of Medicine, Atlanta, Georgia
- Robert J. Boland, M.D., Vice Chair of Education, Department of Psychiatry, Brigham and Women’s Hospital/Harvard Medical School, Boston, Massachusetts
- Vivek Datta, M.D., M.P.H., Assistant Clinical Professor, Department of Psychiatry, University of California, San Francisco, California
- Arden D. Dingle, M.D., Professor, Psychiatry, UT Rio Grande Valley School of Medicine, Harlingen, Texas
- Annette M. Matthews, M.D., Psychiatrist, Portland Veterans Affairs Medical Center, Portland, Oregon; Associate Professor, Department of Psychiatry and Department of Medical Informatics and Clinical Epidemiology, Oregon Health & Science University, Portland, Oregon
- Lindsay J. Moskowitz, M.D., Director, Eating Disorders Service, North Shore–Long Island Jewish Medical Center, New Hyde Park, New York
- Shawn Sidhu, M.D., Associate Training Director, Rural and Community Training, University of New Mexico (UNM) General Psychiatry Residency Program; Assistant Medical Director, UNM-IHS Telebehavioral Health Program, Assistant Professor, UNM Department of Psychiatry, Albuquerque, New Mexico
- Randon S. Welton, M.D., Associate Professor, Director of Residency Training, Department of Psychiatry, Wright State University, Dayton, Ohio
Disclosures of Interests
- James W. Jefferson, M.D., Emeritus Professor of Psychiatry, University of Wisconsin School of Medicine and Public Health; Distinguished Senior Scientist, Madison Institute of Medicine, Inc.; President, Healthcare Technology Systems, Inc., Madison, Wisconsin. Stock Shareholder: GlaxoSmithKline
- Vishal Madaan, M.D., Associate Professor of Psychiatry, Associate Training Director, Child and Adolescent Psychiatry Program, University of Virginia Health System, Charlottesville, Virginia. Research Support: Allergan, Curemark, Medgenics, Pfizer, Purdue, Supernus
Optimal System Configuration:
- Flash Player: Adobe Flash Player 10.3+
- Browser: Firefox (latest version), Internet Explorer 8.0+, Safari 7.0+, Microsoft Edge (latest version) or Google Chrome (latest version)
- Operating System: Windows XP+ or Mac OS X 10.4+
- Internet Connection: 1 Mbps or higher
- Windows PC: 500-MHz Pentium II; Windows XP or higher; 128 MB RAM; Video Card at least 64MB of video memory; Macromedia Flash Player 10.3 or higher; Sound Card at least 16-bit; audio playback with speakers for programs with video content
- Macintosh:Mac OS X 10.4+ or higher with latest updates installed; 1.83MHz Intel Core Duo or faster; RAM: 128MB or more; Video Card: at least 64MB of video memory; Sound Card: at least 16-bit; audio playback with speakers for programs with video content
For assistance: Contact firstname.lastname@example.org for questions about this course | Contact email@example.com for technical assistance